Key points are not available for this paper at this time.
A 12‐week randomized trial involving 147 participants has found that topiramate was as effective as naltrexone in reducing drinking behaviors in patients with alcohol use disorder (AUD). A secondary analysis found no association between two gene polymorphisms and patient response to the medication treatments.
A Wed, study studied this question.